Study Stopped
Laproscopic procedure not offered at this time; will not be offered for the foreseeable, thus we are unable to randomize participants between the two arms.
Comparison of Laparoscopic to Vaginal Surgical Repair for Uterine Prolapse
Randomized Trial Comparing Vaginal Hysterectomy to Laparoscopic Supracervical Hysterectomy With Vault Suspension for Symptomatic Uterine Prolapse
1 other identifier
interventional
14
1 country
1
Brief Summary
Investigators intend to conduct a prospective randomized trial to compare vaginal hysterectomy with uterosacral colposuspension to laparoscopic supracervical hysterectomy with sacrocervicopexy. Both surgeries are minimally-invasive surgical standards of care for uterine prolapse repair. Nobody knows if one procedure is superior to the other, as they have not been compared directly. The investigators hypothesize that there is no difference in objective, subjective, or cost-effectiveness between the two procedures for up to two years after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2012
CompletedFirst Posted
Study publicly available on registry
May 9, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedMarch 4, 2022
March 1, 2022
2.3 years
May 4, 2012
March 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Whether or not POPQ points AA, BA, Ap, or Bp are at less than 0 cm from the hymen OR whether point C descends less than 1/3 of the total vaginal length (TVL)
24 months
Absence of re-treatment for prolapse at 2 years
24 months
A negative response to "Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?"
This is a question from the standardized questionnaire called Pelvic Floor Discomfort Inventory (PFDI).
24 months
Secondary Outcomes (4)
Changes in POPQ measurements
baseline, 6 week, and 3, 12, and 24 months
Changes in Patient-reported quality of life scores from the EQ-5D, PFDI, PFIQ, SF-12, Standard Gamble Interview, Pain Scale and Activity Assessment
baseline, 3, 12, and 24 months
Change in patient reported sexual questionnaire, PISQ
baseline, 3, 12 and 24 months
Frequencies of surgical and post-operative complications
up to 2 years post-operatively
Study Arms (2)
Laparoscopic Repair
ACTIVE COMPARATORLaparoscopic supracervical hysterectomy with sacropexy
Vaginal Repair
ACTIVE COMPARATORVaginal hysterectomy with uterosacral colposuspension
Interventions
Will involve laparoscopic entry to the abdomen to remove the uterus and suspension of the cervix and vaginal cuff to the sacrum with mesh. We will allow surgeons to conduct the surgery as they have perfected it
Will involve removing the uterus vaginally followed by suspending the vaginal cuff to the high (proximal) uterosacral ligaments bilaterally restoring the vagina to its normal axis.
Eligibility Criteria
You may qualify if:
- Patients with primary symptomatic uterine prolapse
- ≥ 18 years of age
- Considering pelvic reconstructive surgery
You may not qualify if:
- Unwillingness to be randomized to one of two surgical approaches
- Pregnant or planning to maintain their future fertility
- Unable to have general anesthesia
- Currently undergoing chemotherapy OR has current or history of pelvic radiation
- Previous adverse reaction to synthetic mesh
- Recent history of abnormal paps (past 10 years)
- Cervical or uterine cancers
- Previous hysterectomy
- Previous central vault or uterine prolapse repair
- Uterus ≥ 14 weeks size
- Uterine cancer
- History of significant pelvic adhesive disease
- Elongated cervix (length D to C \> 6cm)
- Fibroid ≥ 7cm
- Post menopausal with enlarged uterus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham And Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vatche A Minassian, MD, MPH
Brigham and Women's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Urogynecology
Study Record Dates
First Submitted
May 4, 2012
First Posted
May 9, 2012
Study Start
January 1, 2013
Primary Completion
May 1, 2015
Study Completion
May 1, 2015
Last Updated
March 4, 2022
Record last verified: 2022-03